Vaginal transmission of cell-associated HIV-1 in the mouse is blocked by a topical, membrane-modifying agent

Kristen V. Khanna, Kevin J. Whaley, Larry Zeitlin, Thomas R. Moench, Karim Mehrazar, Richard A. Cone, Zhaohao Liao, James Hildreth, Timothy E. Hoen, Leonard Shultz, Richard B. Markham

Research output: Contribution to journalArticle

111 Citations (Scopus)

Abstract

Because both HIV-1 virions and HIV-infected cells are present in the semen and cervical mucus of infected individuals, HIV-1 prevention strategies must consider both cell-free and cell-associated virus. Antibodies that target HIV-1 virions have been shown to prevent vaginal transmission of cell-free virus in macaques, but since cell-associated transmission has not been reliably demonstrated in this model system, no strategies to prevent such transmission have been tested. We have employed a mouse model in which SCID mice carry human peripheral blood leukocytes (HuPBLs). In these mice, vaginal transmission of cell-associated, but not cell-free, HIV-1 transmission occurs, mediated by transepithelial migration of HIV-infected cells. Topical application of β-cyclodextrin (β-CD), a cholesterol-sequestering agent that interferes with cell migration and budding of virus from lipid rafts, blocks transmission of cell-associated HIV-1. The HuPBL-SCID model of vaginal HIV-1 transmission should prove useful for investigating cell-associated HIV-1 transmucosal HIV-1 transmission, as well as for screening reagents for their potential efficacy in preventing sexual HIV-1 transmission.

Original languageEnglish (US)
Pages (from-to)205-211
Number of pages7
JournalJournal of Clinical Investigation
Volume109
Issue number2
DOIs
StatePublished - 2002
Externally publishedYes

Fingerprint

HIV-1
Membranes
Virion
Sequestering Agents
Leukocytes
HIV
Virus Release
Cervix Mucus
Transendothelial and Transepithelial Migration
Satellite Viruses
SCID Mice
Cyclodextrins
Macaca
Semen
Cell Movement
Cholesterol
Viruses
Lipids
Antibodies

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Khanna, K. V., Whaley, K. J., Zeitlin, L., Moench, T. R., Mehrazar, K., Cone, R. A., ... Markham, R. B. (2002). Vaginal transmission of cell-associated HIV-1 in the mouse is blocked by a topical, membrane-modifying agent. Journal of Clinical Investigation, 109(2), 205-211. https://doi.org/10.1172/JCI200213236

Vaginal transmission of cell-associated HIV-1 in the mouse is blocked by a topical, membrane-modifying agent. / Khanna, Kristen V.; Whaley, Kevin J.; Zeitlin, Larry; Moench, Thomas R.; Mehrazar, Karim; Cone, Richard A.; Liao, Zhaohao; Hildreth, James; Hoen, Timothy E.; Shultz, Leonard; Markham, Richard B.

In: Journal of Clinical Investigation, Vol. 109, No. 2, 2002, p. 205-211.

Research output: Contribution to journalArticle

Khanna, KV, Whaley, KJ, Zeitlin, L, Moench, TR, Mehrazar, K, Cone, RA, Liao, Z, Hildreth, J, Hoen, TE, Shultz, L & Markham, RB 2002, 'Vaginal transmission of cell-associated HIV-1 in the mouse is blocked by a topical, membrane-modifying agent', Journal of Clinical Investigation, vol. 109, no. 2, pp. 205-211. https://doi.org/10.1172/JCI200213236
Khanna, Kristen V. ; Whaley, Kevin J. ; Zeitlin, Larry ; Moench, Thomas R. ; Mehrazar, Karim ; Cone, Richard A. ; Liao, Zhaohao ; Hildreth, James ; Hoen, Timothy E. ; Shultz, Leonard ; Markham, Richard B. / Vaginal transmission of cell-associated HIV-1 in the mouse is blocked by a topical, membrane-modifying agent. In: Journal of Clinical Investigation. 2002 ; Vol. 109, No. 2. pp. 205-211.
@article{dc7c2af9348b40829137efecc9a6adf3,
title = "Vaginal transmission of cell-associated HIV-1 in the mouse is blocked by a topical, membrane-modifying agent",
abstract = "Because both HIV-1 virions and HIV-infected cells are present in the semen and cervical mucus of infected individuals, HIV-1 prevention strategies must consider both cell-free and cell-associated virus. Antibodies that target HIV-1 virions have been shown to prevent vaginal transmission of cell-free virus in macaques, but since cell-associated transmission has not been reliably demonstrated in this model system, no strategies to prevent such transmission have been tested. We have employed a mouse model in which SCID mice carry human peripheral blood leukocytes (HuPBLs). In these mice, vaginal transmission of cell-associated, but not cell-free, HIV-1 transmission occurs, mediated by transepithelial migration of HIV-infected cells. Topical application of β-cyclodextrin (β-CD), a cholesterol-sequestering agent that interferes with cell migration and budding of virus from lipid rafts, blocks transmission of cell-associated HIV-1. The HuPBL-SCID model of vaginal HIV-1 transmission should prove useful for investigating cell-associated HIV-1 transmucosal HIV-1 transmission, as well as for screening reagents for their potential efficacy in preventing sexual HIV-1 transmission.",
author = "Khanna, {Kristen V.} and Whaley, {Kevin J.} and Larry Zeitlin and Moench, {Thomas R.} and Karim Mehrazar and Cone, {Richard A.} and Zhaohao Liao and James Hildreth and Hoen, {Timothy E.} and Leonard Shultz and Markham, {Richard B.}",
year = "2002",
doi = "10.1172/JCI200213236",
language = "English (US)",
volume = "109",
pages = "205--211",
journal = "Journal of Clinical Investigation",
issn = "0021-9738",
publisher = "The American Society for Clinical Investigation",
number = "2",

}

TY - JOUR

T1 - Vaginal transmission of cell-associated HIV-1 in the mouse is blocked by a topical, membrane-modifying agent

AU - Khanna, Kristen V.

AU - Whaley, Kevin J.

AU - Zeitlin, Larry

AU - Moench, Thomas R.

AU - Mehrazar, Karim

AU - Cone, Richard A.

AU - Liao, Zhaohao

AU - Hildreth, James

AU - Hoen, Timothy E.

AU - Shultz, Leonard

AU - Markham, Richard B.

PY - 2002

Y1 - 2002

N2 - Because both HIV-1 virions and HIV-infected cells are present in the semen and cervical mucus of infected individuals, HIV-1 prevention strategies must consider both cell-free and cell-associated virus. Antibodies that target HIV-1 virions have been shown to prevent vaginal transmission of cell-free virus in macaques, but since cell-associated transmission has not been reliably demonstrated in this model system, no strategies to prevent such transmission have been tested. We have employed a mouse model in which SCID mice carry human peripheral blood leukocytes (HuPBLs). In these mice, vaginal transmission of cell-associated, but not cell-free, HIV-1 transmission occurs, mediated by transepithelial migration of HIV-infected cells. Topical application of β-cyclodextrin (β-CD), a cholesterol-sequestering agent that interferes with cell migration and budding of virus from lipid rafts, blocks transmission of cell-associated HIV-1. The HuPBL-SCID model of vaginal HIV-1 transmission should prove useful for investigating cell-associated HIV-1 transmucosal HIV-1 transmission, as well as for screening reagents for their potential efficacy in preventing sexual HIV-1 transmission.

AB - Because both HIV-1 virions and HIV-infected cells are present in the semen and cervical mucus of infected individuals, HIV-1 prevention strategies must consider both cell-free and cell-associated virus. Antibodies that target HIV-1 virions have been shown to prevent vaginal transmission of cell-free virus in macaques, but since cell-associated transmission has not been reliably demonstrated in this model system, no strategies to prevent such transmission have been tested. We have employed a mouse model in which SCID mice carry human peripheral blood leukocytes (HuPBLs). In these mice, vaginal transmission of cell-associated, but not cell-free, HIV-1 transmission occurs, mediated by transepithelial migration of HIV-infected cells. Topical application of β-cyclodextrin (β-CD), a cholesterol-sequestering agent that interferes with cell migration and budding of virus from lipid rafts, blocks transmission of cell-associated HIV-1. The HuPBL-SCID model of vaginal HIV-1 transmission should prove useful for investigating cell-associated HIV-1 transmucosal HIV-1 transmission, as well as for screening reagents for their potential efficacy in preventing sexual HIV-1 transmission.

UR - http://www.scopus.com/inward/record.url?scp=0036150902&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036150902&partnerID=8YFLogxK

U2 - 10.1172/JCI200213236

DO - 10.1172/JCI200213236

M3 - Article

VL - 109

SP - 205

EP - 211

JO - Journal of Clinical Investigation

JF - Journal of Clinical Investigation

SN - 0021-9738

IS - 2

ER -